{ "cik": 1393434, "cik_padded": "0001393434", "entityName": "OCULAR THERAPEUTIX, INC", "fiscal_years": [ { "accn": "0001104659-26-010664", "filed": "2026-02-05", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 12010000.0, "cash": 737060000.0, "eps_diluted": -1.42, "free_cash_flow": -216893000.0, "net_income": -265939000.0, "operating_cash_flow": -204883000.0, "operating_income": -270017000.0, "revenue": 51951000.0, "stockholders_equity": 654310000.0, "total_assets": 808057000.0, "total_liabilities": 153747000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2349757760083141, "revenue_growth_yoy": -0.1847370651099289, "roa_avg2y": -0.4201274573614999, "roa_period_end": -0.3291092088800667, "roe_avg2y": -0.5485234939473256, "roe_period_end": -0.4064419006281426 } }, { "accn": "0001104659-26-010664", "filed": "2026-02-05", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1288000.0, "cash": 392102000.0, "eps_diluted": -1.22, "free_cash_flow": -135965000.0, "net_income": -193506000.0, "operating_cash_flow": -134677000.0, "operating_income": -171781000.0, "revenue": 63723000.0, "stockholders_equity": 315344000.0, "total_assets": 457935000.0, "total_liabilities": 142591000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.45217603632858083, "revenue_growth_yoy": 0.09034443817052512, "roa_avg2y": -0.5450911626138212, "roa_period_end": -0.4225621540174916, "roe_avg2y": -0.9521175964081432, "roe_period_end": -0.6136346339235882 } }, { "accn": "0001558370-25-002000", "filed": "2026-02-05", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6087000.0, "cash": 195807000.0, "eps_diluted": -1.02, "free_cash_flow": -76321000.0, "net_income": -80736000.0, "operating_cash_flow": -70234000.0, "operating_income": -82382000.0, "revenue": 58443000.0, "stockholders_equity": 91131000.0, "total_assets": 252060000.0, "total_liabilities": 160929000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.7659084175527537, "net_margin": -1.381448590934757, "operating_margin": -1.409612785106856, "revenue_growth_yoy": 0.134947760904183, "roa_avg2y": -0.4023231651256139, "roa_period_end": -0.32030468935967626, "roe_avg2y": -1.2763576001897083, "roe_period_end": -0.8859334364815485 } }, { "accn": "0001558370-25-002000", "filed": "2026-02-05", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3715000.0, "cash": 102300000.0, "eps_diluted": -0.97, "free_cash_flow": -63318000.0, "net_income": -71038000.0, "operating_cash_flow": -59603000.0, "operating_income": -78654000.0, "revenue": 51494000.0, "stockholders_equity": 35379000.0, "total_assets": 149289000.0, "total_liabilities": 113910000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.2197066056134998, "net_margin": -1.3795393638093758, "revenue_growth_yoy": 0.18317172924038416, "roa_avg2y": -0.40114519335019877, "roa_period_end": -0.475842158497947, "roe_avg2y": -1.1515505195415714, "roe_period_end": -2.0079142994431725 } }, { "accn": "0001558370-25-002000", "filed": "2025-03-03", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1194000.0, "cash": 164164000.0, "eps_diluted": -0.98, "free_cash_flow": -66744000.0, "net_income": -6553000.0, "operating_cash_flow": -65550000.0, "operating_income": -78037000.0, "revenue": 43522000.0, "stockholders_equity": 87999000.0, "total_assets": 204887000.0, "total_liabilities": 116888000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.3282878214525164, "net_margin": -0.15056752906575985, "revenue_growth_yoy": 1.5008331896799403, "roa_avg2y": -0.02807927155865024, "roa_period_end": -0.031983483578753164, "roe_avg2y": -0.07986885565590454, "roe_period_end": -0.07446675530403754 } }, { "accn": "0001558370-24-002902", "filed": "2024-03-11", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 841000.0, "cash": 228057000.0, "eps_diluted": -2.56, "free_cash_flow": -54395000.0, "net_income": -155636000.0, "operating_cash_flow": -53554000.0, "operating_income": -62847000.0, "revenue": 17403000.0, "stockholders_equity": 76095000.0, "total_assets": 261863000.0, "total_liabilities": 185768000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.441264209212169, "revenue_growth_yoy": 3.1171043293115686, "roa_avg2y": -0.9138850802840844, "roa_period_end": -0.5943413158789138, "roe_avg2y": -4.295480576830194, "roe_period_end": -2.0452854983901703 } }, { "accn": "0001558370-23-002908", "filed": "2023-03-06", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2238000.0, "cash": 54437000.0, "eps_diluted": -1.91, "free_cash_flow": -79816000.0, "net_income": -86372000.0, "operating_cash_flow": -77578000.0, "operating_income": -85802000.0, "revenue": 4227000.0, "stockholders_equity": -3630000.0, "total_assets": 78740000.0, "total_liabilities": 82370000.0 }, "period_end": "2019-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 1.1241206030150754, "roa_avg2y": -1.1380984695255727, "roa_period_end": -1.0969265938531878, "roe_avg2y": -5.357233679640254 } }, { "accn": "0001558370-22-002363", "filed": "2022-02-28", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1889000.0, "cash": 54062000.0, "free_cash_flow": -51116000.0, "net_income": -59978000.0, "operating_cash_flow": -49227000.0, "operating_income": -59118000.0, "revenue": 1990000.0, "stockholders_equity": 35875000.0, "total_assets": 73043000.0, "total_liabilities": 37168000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.0360418118466899, "revenue_growth_yoy": 0.034841393655746226, "roa_avg2y": -0.9336986471970983, "roa_period_end": -0.8211327574168641, "roe_avg2y": -1.9340879042920254, "roe_period_end": -1.6718606271777003 } }, { "accn": "0001558370-20-002537", "filed": "2020-03-12", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 8252000.0, "cash": 41538000.0, "free_cash_flow": -58725000.0, "net_income": -63386000.0, "operating_cash_flow": -50473000.0, "operating_income": -61923000.0, "revenue": 1923000.0, "stockholders_equity": 26147000.0, "total_assets": 55431000.0, "total_liabilities": 29284000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.1199755230045512, "roa_avg2y": -0.9724016261409834, "roa_period_end": -1.143511753351013, "roe_avg2y": -1.622058729447892, "roe_period_end": -2.424216927372165 } }, { "accn": "0001558370-20-002537", "filed": "2020-03-12", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1919000.0, "cash": 32936000.0, "free_cash_flow": -35920000.0, "net_income": -44703000.0, "operating_cash_flow": -34001000.0, "operating_income": -43326000.0, "stockholders_equity": 52008000.0, "total_assets": 74939000.0, "total_liabilities": 22931000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.44091293647131213, "roa_period_end": -0.5965251738080305, "roe_period_end": -0.8595408398707892 } } ], "latest_filing": { "accn": "0001104659-26-010664", "filed": "2026-02-05", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001393434.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001393434.json" }, "ticker": "OCUL" }